International audienceTumor cells succumb to chemotherapy while releasing ATP. We have found that extracellular ATP attracts dendritic cell (DC) precursors into the tumor bed, facilitates their permanence in the proximity of dying cells and promotes their differentiation into mature DCs endowed with the capacity of presenting tumor-associated antigens
Head and neck squamous cell carcinoma (HNSCC) is an aggressive malignancy. Tumor-derived exosomes (T...
Extracellular ATP released into the extracellular environment is thought to act as a danger signal o...
It has been reported that ATP inhibits or stimulates lymphoid cell proliferation depending on the ce...
By destroying tumor cells, conventional anticancer therapies may stimulate the host immune system to...
In this issue of Immunity, Ma et al. (2013) demonstrate that neoplastic cell release of ATP drives r...
Chemotherapy-induced immunogenic cell death can favor dendritic cell (DC) cross-priming of tumor-ass...
Chemotherapy-induced immunogenic cell death can favor dendritic cell (DC) cross-priming of tumor-ass...
Chemotherapy-induced immunogenic cell death can favor dendritic cell (DC) cross-priming of tumor-ass...
We previously reported that chronic stimulation with low, noncytotoxic doses of extracellular adenos...
Dendritic cells (DCs) express functional purinergic receptors, but the effects of purine nucleotides...
Dendritic cells (DCs) present foreign antigens to T cells via the major histocompatibility complex (...
International audienceSome anticancer agents induce immunogenic cell death that is accompanied by th...
Adenosine triphosphate (ATP) is actively released in the extracellular environment in response to ti...
The main obstacle to the success of the immunotherapy is the well established tumor-induced toleranc...
While intracellular adenosine triphosphate (ATP) occupies a key position in the bioenergetic metabol...
Head and neck squamous cell carcinoma (HNSCC) is an aggressive malignancy. Tumor-derived exosomes (T...
Extracellular ATP released into the extracellular environment is thought to act as a danger signal o...
It has been reported that ATP inhibits or stimulates lymphoid cell proliferation depending on the ce...
By destroying tumor cells, conventional anticancer therapies may stimulate the host immune system to...
In this issue of Immunity, Ma et al. (2013) demonstrate that neoplastic cell release of ATP drives r...
Chemotherapy-induced immunogenic cell death can favor dendritic cell (DC) cross-priming of tumor-ass...
Chemotherapy-induced immunogenic cell death can favor dendritic cell (DC) cross-priming of tumor-ass...
Chemotherapy-induced immunogenic cell death can favor dendritic cell (DC) cross-priming of tumor-ass...
We previously reported that chronic stimulation with low, noncytotoxic doses of extracellular adenos...
Dendritic cells (DCs) express functional purinergic receptors, but the effects of purine nucleotides...
Dendritic cells (DCs) present foreign antigens to T cells via the major histocompatibility complex (...
International audienceSome anticancer agents induce immunogenic cell death that is accompanied by th...
Adenosine triphosphate (ATP) is actively released in the extracellular environment in response to ti...
The main obstacle to the success of the immunotherapy is the well established tumor-induced toleranc...
While intracellular adenosine triphosphate (ATP) occupies a key position in the bioenergetic metabol...
Head and neck squamous cell carcinoma (HNSCC) is an aggressive malignancy. Tumor-derived exosomes (T...
Extracellular ATP released into the extracellular environment is thought to act as a danger signal o...
It has been reported that ATP inhibits or stimulates lymphoid cell proliferation depending on the ce...